May 30th 2024
The annual conference taking place from June 1 to June 5, 2024, will feature sessions on the relationship between mental health and sleep, artificial intelligence in sleep, and different sleep conditions.
Advancing Targeted Therapies Aimed at Smoldering Disease in Multiple Sclerosis
Leveraging Managed Care to Optimize Best Practices in the Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Advances and Best Practices for Managed Care Pharmacists and the Treatment of Patients with Alpha-1 Antitrypsin Deficiency
Improving Outcomes and Quality of Care in Spinal Muscular Atrophy: Updates in Treatment Advances
New and Emerging Treatment Strategies for Myasthenia Gravis: The Role of the Specialty Pharmacist
Improving Treatment Access for Spinal Muscular Atrophy: How Managed Care Strategies Can Ease Clinical and Caregiver Burden
Assessing the Treatment Landscape for Multiple Sclerosis to Better Individualize Care
Understanding the Relationship Between Sleep Apnea, Atrial Fibrillation
Dr Susan Millard on Assessment, Treatment Process of Pediatric OSA
How Do Anxiety, Depression Affect Severity of Obstructive Sleep Apnea?
Dr Robert Iannone on Sleep Health Educational Content Initiative
Assessing Sleep Attributes Among Health Workers During the COVID-19 Pandemic
What Is the Relationship Between OSA, Cardiovascular Disease?